Showing results (251-260 of 372) with videos related to
Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.International Journal of Oncology|September 30, 2009
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomasJean-Louis Boulay, Mihai-Constantin S Ionescu, Balasubramanian Sivasankaran, et al.Brain Pathology (Zurich, Switzerland)|February 5, 2017
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical courseKatharina Heß, Jan Purrucker, Ute Hegenbart, et al.Genes, Chromosomes & Cancer|November 7, 2003
10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IVPeter H Wessels, Albert Twijnstra, Bela Kubat, et al.European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 20, 2014
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescentsVeronika Dunkl, Corvin Cleff, Gabriele Stoffels, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma NetworkMichael Weller, Jörg Felsberg, Christian Hartmann, et al.Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PETNorbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.Pageof 38